PLANT-DERIVED MORIN AS A CONTROLLED-RELEASE ANTIMICROBIAL AGENT FOR PERIODONTAL THERAPY: A NATURAL ALTERNATIVE TO ANTIBIOTICS
Authors:
- Pedro Guimarães Sampaio Trajano Dos SantosPSPedro Guimarães Sampaio Trajano Dos Santos
- Rosana Maria Coelho TravassosRTRosana Maria Coelho Travassos
- Priscila ProsiniPPPriscila Prosini
- Adriane Tenório Dourado ChavesACAdriane Tenório Dourado Chaves
- Vânia Cavalcanti Ribeiro da SilvaVSVânia Cavalcanti Ribeiro da Silva
- Viviane Ferreira Guimarães XavierVXViviane Ferreira Guimarães Xavier
- Maria Do Socorro Orestes CardosoMCMaria Do Socorro Orestes Cardoso
- Silvana Maria Orestes CardosoSCSilvana Maria Orestes Cardoso
- Eliana Santos Lyra Da PazEPEliana Santos Lyra Da Paz
- Moacir Moreno da Silva NetoMNMoacir Moreno da Silva Neto
- Maria Victoria de Lima SantosMSMaria Victoria de Lima Santos
- Verônica Maria de Sá RodriguesVRVerônica Maria de Sá Rodrigues
Open Access
- 1 November 2025
- journal article
- Published by Seven Events in ARACÊ
- Vol. 7 (11) , e9789
Abstract
Objective:This narrative literature review aims to analyze current evidence on the potential use of morin, a natural flavonoid extracted from plants such as guava leaves, apple peels, and fig trees, as a controlled-release antimicrobial and anti-inflammatory agent for periodontal therapy. The focus is on its biological properties, formulation strategies using biopolymers, and its potential role as a natural alternative to conventional antibiotics in the management of periodontal disease. Methodology: A comprehensive search was conducted in PubMed, Scopus, Web of Science, and Google Scholar databases using combinations of the keywords “Morin,” “Periodontal Disease,” “Controlled Release,” “Polymer,” and “Antimicrobial Agent.” Boolean operators “AND” and “OR” were used to refine results. Both in vitro and preclinical studies published in English between 2000 and 2025 were included, emphasizing the encapsulation of morin in biodegradable polymers and its biological effects on oral biofilms, inflammatory mediators, and tissue healing. Results: The reviewed literature demonstrates that morin exhibits significant antimicrobial, anti-inflammatory, and antioxidant properties, reducing bacterial growth and oxidative stress associated with periodontal inflammation. In vitro studies conducted at the São Paulo State University (UNESP) have shown that morin-loaded polymeric microparticles, formulated with sodium alginate and gellan gum, promote controlled release and maintain biological activity against multispecies biofilms mimicking periodontal conditions. These systems may overcome the limitations of conventional antibiotics, such as bacterial resistance and undesirable side effects. However, clinical validation remains limited, and further animal and human trials are necessary to confirm efficacy and safety. Conclusion: Morin-based delivery systems represent a promising, plant-derived alternative for adjunctive periodontal therapy, offering targeted antimicrobial activity and biocompatible release profiles. Standardization of polymeric formulations and clinical studies are required to translate these experimental findings into practical dental applications.Keywords
This publication has 5 references indexed in Scilit:
- Anti-inflammatory, antioxidant, and antimicrobial evaluation of morinArchives of Oral Biology, 2025
- Antibiotics in periodontal treatment: an umbrella reviewFrontiers in Cellular and Infection Microbiology, 2025
- Diagnostic performance of the AAP/EFP classification and the CDC/AAP case definition among pregnant women and a practical screening tool for maternal periodontal diseasesJournal of Periodontal Research, 2022
- Selective Antimicrobial Therapies for Periodontitis: Win the “Battle and the War”International Journal of Molecular Sciences, 2021
- Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of InterventionsCochrane Database of Systematic Reviews, 2019